Skip to main content
AJJ MEDTECH HOLDINGS LIMITED logo

AJJ MEDTECH HOLDINGS LIMITED — Investor Relations & Filings

Ticker · 584 ISIN · SG0584008601 SGX Manufacturing
Open in API
Filings indexed 47 across all filing types
Latest filing 2026-05-26 AGM Information
Country SG Singapore
Listing SGX 584

About AJJ MEDTECH HOLDINGS LIMITED

https://www.ajjmedtech.com.sg/

AJJ Medtech Holdings Limited is a healthcare technology platform group and integrated solutions provider dedicated to advancing healthcare through innovation. The company leverages digitization, artificial intelligence, and robotics to offer a comprehensive medical ecosystem. Its core business encompasses high-tech medical devices, superior quality products, and healthcare consumables, with a portfolio of over 6,000 items. This includes laboratory plastic consumables and advanced diagnostic imaging systems that utilize AI technology. Anchored by regulatory expertise and a turnkey supply chain, AJJ Medtech Holdings Limited serves the healthcare sector, including national-level research and clinical institutions.

Recent filings

Filing Released Lang Actions
General Announcement::Minutes of the Annual General Meeting held on 30 April 2026
AGM Information Classification · 85% confidence The document is the official Minutes of the Annual General Meeting of AJJ MedTech Holdings Limited, detailing the date, venue, attendees, procedural matters, resolutions proposed and their poll results. This is not simply an announcement nor a transcript of an earnings call, but the formal AGM minutes. Such content falls under AGM Information.
2026-05-26 English
Financial Statements and Related Announcement::First Quarter Results
Interim / Quarterly Report Classification · 90% confidence The document is titled “Condensed interim financial statements for the first quarter ended 31 March 2026” and contains full interim consolidated financial statements (profit or loss, statements of financial position, changes in equity, cash flows) prepared under Singapore IFRS for the quarter. This is a comprehensive quarterly/interim report, not just a brief earnings release or announcement. Therefore it should be classified as an Interim/Quarterly Report (IR). Q1 2026
2026-05-14 English
General Announcement::Changes to Composition of Board
Board/Management Information Classification · 92% confidence The document is an official announcement by AJJ Medtech Holdings Limited regarding changes to its Board of Directors and the re-designation of its Chief Executive Officer. It specifically details the composition of the Board and references Listing Manual rules for disclosure. There is no presentation of financial statements, voting results, or other report content. This clearly falls under board/management information.
2026-05-04 English
General Announcement::CESSATION OF CEO AND EXECUTIVE DIRECTOR AND APPOINTMENT OF CEO AND EXECUTIVE DIRECTOR
Board/Management Information Classification · 86% confidence The document is a formal announcement by AJJ Medtech Holdings Limited disclosing the cessation of the current Chief Executive Officer and Executive Director and the appointment of a new Chief Executive Officer and Executive Director, which clearly constitutes a board-level management change. It does not contain financial statements or serve as a report publication announcement; rather, it specifically relates to senior management alterations. Therefore, it should be classified under Board/Management Information (MANG).
2026-05-04 English
Annual Reports and Related Documents::
Environmental & Social Information Classification · 95% confidence The document is titled 'FY2025 Sustainability Report' and contains extensive sections on climate change, environmental data, social responsibility, governance, stakeholder engagement, and ESG performance metrics. It is a full, standalone ESG report (148,558 characters) rather than a brief announcement or supplementary spreadsheet. This matches the definition of an Environmental & Social Information report (Code: SR).
2026-04-30 English
General Announcement::Responses to Questions received from SIAS in relation to the Annual Report for FY2025
Board/Management Information Classification · 95% confidence The document is a detailed response from the company to questions raised by the Securities Investors Association (Singapore) regarding the company's Annual Report for the financial year ended 31 December 2025. It discusses financial results, operational updates, audit committee explanations on discrepancies between unaudited and audited financial statements, and governance matters related to the Annual Report. The content is clearly linked to the Annual Report and provides management and audit committee commentary on the report's contents and related financial disclosures. It is not the Annual Report itself but a supplementary document responding to queries about it. Given the detailed nature and length (15,000 characters), it is not a brief announcement or certification but a substantive management and audit committee information document related to the Annual Report. Therefore, the best fitting classification is "Board/Management Information (MANG)" as it involves management and board responses and explanations related to the Annual Report and financial disclosures.
2026-04-24 English

Browse filings by year

2 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.